Abstract
A series of 8 europium (III) tris-β-diketonates with common formula Eu(L)3Int, where L is acetyl acetone, thenoyltrifluoroacetone, benzoylacetone, dibenzoylmethane and Int is 1,10-phenanthroline or 2,2-bipyridine, together with an analog without intercalating moiety (Eu(III)(acetyl acetone)3(H2O)2) were tested for cytotoxic activity in a panel of human tumor cell lines, using the MTT-dye reduction assay. The panel consisted of the leukemias HL-60, BV-173, SKW- 3, K-562, LAMA-84 and the urinary bladder carcinoma 5637. The tested europium complexes with appended intercalator moieties exhibited profound cytotoxic effects with IC50 values lower or comparable to those of the referent drug cis-DDP, whereby the 1,10-phenanthroline bearing compounds were invariably more active than the corresponding 2,2-bipyridine analogs. The established low cytotoxic potential of Eu(III)(acetyl acetone)3(H2O)2 as compared to its highly potent analogs with either 1,10-phenanthroline or 2,2-bipyridine ligand demonstrated that the abundance of intercalating motif is a mandatory structural prerequisite for optimal activity within this series of cytotoxic agents. Selected compound caused DNA-fragmentation when applied in cytotoxic concentration, which suggests that the induction of programmed cell death (apoptosis) at least partly mediates the cytotoxic effects of tested compounds. Taken together our data give us reason to conclude that the presented Eu(III) complexes represent a unique class of cytotoxic metal coordination compounds and necessitate further detailed evaluation in order to define the structure activity relationships as well as the predominant mode of action. To the best knowledge of the authors this is among the first reports of potent cytotoxic Eu(III) compounds.
Keywords: Europium(III), βdiketone, 1,10-phenanthroline, 2,2'-bipyridine, MTT-assay, apoptosis
Medicinal Chemistry
Title: Evaluation of the Cytotoxic and Pro-Apoptotic Activities of Eu(III) Complexes with Appended DNA Intercalators in a Panel of Human Malignant Cell Lines
Volume: 2 Issue: 5
Author(s): Georgi Momekov, Todor Deligeorgiev, Aleksey Vasilev, Kalina Peneva, Spiro Konstantinov and Margarita Karaivanova
Affiliation:
Keywords: Europium(III), βdiketone, 1,10-phenanthroline, 2,2'-bipyridine, MTT-assay, apoptosis
Abstract: A series of 8 europium (III) tris-β-diketonates with common formula Eu(L)3Int, where L is acetyl acetone, thenoyltrifluoroacetone, benzoylacetone, dibenzoylmethane and Int is 1,10-phenanthroline or 2,2-bipyridine, together with an analog without intercalating moiety (Eu(III)(acetyl acetone)3(H2O)2) were tested for cytotoxic activity in a panel of human tumor cell lines, using the MTT-dye reduction assay. The panel consisted of the leukemias HL-60, BV-173, SKW- 3, K-562, LAMA-84 and the urinary bladder carcinoma 5637. The tested europium complexes with appended intercalator moieties exhibited profound cytotoxic effects with IC50 values lower or comparable to those of the referent drug cis-DDP, whereby the 1,10-phenanthroline bearing compounds were invariably more active than the corresponding 2,2-bipyridine analogs. The established low cytotoxic potential of Eu(III)(acetyl acetone)3(H2O)2 as compared to its highly potent analogs with either 1,10-phenanthroline or 2,2-bipyridine ligand demonstrated that the abundance of intercalating motif is a mandatory structural prerequisite for optimal activity within this series of cytotoxic agents. Selected compound caused DNA-fragmentation when applied in cytotoxic concentration, which suggests that the induction of programmed cell death (apoptosis) at least partly mediates the cytotoxic effects of tested compounds. Taken together our data give us reason to conclude that the presented Eu(III) complexes represent a unique class of cytotoxic metal coordination compounds and necessitate further detailed evaluation in order to define the structure activity relationships as well as the predominant mode of action. To the best knowledge of the authors this is among the first reports of potent cytotoxic Eu(III) compounds.
Export Options
About this article
Cite this article as:
Momekov Georgi, Deligeorgiev Todor, Vasilev Aleksey, Peneva Kalina, Konstantinov Spiro and Karaivanova Margarita, Evaluation of the Cytotoxic and Pro-Apoptotic Activities of Eu(III) Complexes with Appended DNA Intercalators in a Panel of Human Malignant Cell Lines, Medicinal Chemistry 2006; 2 (5) . https://dx.doi.org/10.2174/157340606778250234
DOI https://dx.doi.org/10.2174/157340606778250234 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tumor Angiogenesis: A Potential Target In Cancer Control by Phytochemicals
Current Cancer Drug Targets Advanced Platelet-Rich Fibrin Extract Treatment Promotes the Proliferation and Differentiation of Human Adipose-Derived Mesenchymal Stem Cells through Activation of Tryptophan Metabolism
Current Stem Cell Research & Therapy Therapeutic Targeting of Cancers with Loss of PTEN Function
Current Drug Targets New Robotic Technologies in Cancer Colon Screening
Clinical Cancer Drugs Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences
Current Drug Delivery Disruptive Nanozyme Technology for Futuristic Bio-Medical and Bio-imaging Applications
Current Nanoscience The cytotoxic effect of GW843682X on nasopharyngeal carcinoma
Anti-Cancer Agents in Medicinal Chemistry The Applications of Targeting Anti-Cancer Agents in Cancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate
Current Cancer Drug Targets Patent Selections :
Recent Patents on Biomarkers Prognostic and Predictive Biomarkers in Cancer
Current Cancer Drug Targets Meet Our Editorial Board Member
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Multicomponent Reactions in Antimitotic Drug Discovery
Current Topics in Medicinal Chemistry Properties of Cell Sources in Tissue-Engineered Three-dimensional Oral Mucosa Model: A Review
Current Stem Cell Research & Therapy A Role for Milk Proteins and their Peptides in Cancer Prevention
Current Pharmaceutical Design Neurotrophic Factors in Combination: A Possible new Therapeutic Strategy to Influence Pathophysiology of Spinal Cord Injury and Repair Mechanisms
Current Pharmaceutical Design Endothelin Receptors in Gastrointestinal Smooth Muscle
Current Protein & Peptide Science Potential Therapeutic Application of the Association of Vitamins C and K3 in Cancer Treatment
Current Medicinal Chemistry Chemistry in the Bioactivity of Chlorophylls: An Overview
Current Medicinal Chemistry Potential Anticancer Properties of Bisphosphonates: Insights From Preclinical Studies
Anti-Cancer Agents in Medicinal Chemistry